Clinical Trials Sponsored by Walter Ling

Total 7669 results

Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD | CAPD | APD

Taiwan, Korea, Republic of, Singapore, Hong Kong, Russian Federation
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD

Australia, Canada, New Zealand
Baxter Healthcare Corporation

Terminated

Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis

Gastroenteritis | Dehydration

United States, Canada
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions

Intraperitoneal Adhesions

Denmark, Poland, Sweden
Baxter Healthcare Corporation

Completed

Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac Output

Heart Failure
Baxter Healthcare Corporation

Completed

Effects of IV Chloride Content on Outcomes

SIRS | Balanced Fluids | Plasmalyte

United States
Baxter Healthcare Corporation

Withdrawn

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Peritoneal Dialysis | Hypertriglyceridemia

United States
Baxter Healthcare Corporation

Completed

Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

Deep Partial or Full Thickness Wounds

United States
Baxter Healthcare Corporation

Completed

Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis

Heart Failure | Kidney Disease

United States
Baxter Healthcare Corporation

Completed

Fibrin Sealant for the Sealing of Dura Sutures

Dura Defects | Pathological Processes in the Posterior Fossa

United States, Canada
Warner Chilcott
Sanofi

Completed

Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

Osteoporosis

United States, Canada
Warner Chilcott
Sanofi

Completed

A Study of Monthly Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Brazil, France, Spain, Hungary, Poland, Finland, Norway, Belgium, Argentina, Estonia, Lebanon, Canada, Australia
Baxter Healthcare Corporation

Completed

e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study (e-STEPS)

Endotoxin-associated Sterile Peritonitis

United Kingdom, Germany, Hungary, Netherlands, Portugal
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures

Facial Rhytidectomy (Face-lift)

United States
Baxter Healthcare Corporation

Completed

Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy

Face-lift | Facial Rhytidectomy

United States
Warner Chilcott
Sanofi

Completed

Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate

Bioavailability

United States
Baxter Healthcare Corporation

Completed

Safety During Use of Paediatric Triple Chamber Bag Formulas

Infant, Premature, Diseases | Digestive System Disorders | Infant Nutrition Disorders

France, Belgium
Baxter Healthcare Corporation

Completed

A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis

End Stage Renal Disease

Sweden
Heidelberg University
Asklepios Kliniken Hamburg GmbH; Lung Clinic Hemer; Otto Wagner Hospital

Unknown

Spiration Valve System 9 mm European Post Market Evaluation Study

Emphysema

Germany
Baxter Healthcare Corporation

Not yet recruiting

ModPG3 Neo-Infant ISO 81060

Blood Pressure
Baxter Healthcare Corporation

Recruiting

PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery

Adhesion

United States, Germany
Baxter Healthcare Corporation

Recruiting

BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)

Congenital Heart Disease in Children

Japan
Baxter Healthcare Corporation

Not yet recruiting

Doxil/Caelyx BE Study

Multiple Myeloma | Ovarian Cancer | Metastatic Breast Cancer | AIDS-related Kaposi Sarcoma
Baxter Healthcare Corporation

Completed

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

Essential Fatty Acid Deficiency (EFAD)

United States
Baxter Healthcare Corporation

Completed

Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode

End Stage Renal Disease

Austria
Baxter Healthcare Corporation

Completed

Validation of a Sensor for Non-Invasive Measurements

Hypertension | CHF | Renal Disease

United States
Baxter Healthcare Corporation

Completed

Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection

Air Leak From Lung

Italy, Spain
Baxter Healthcare Corporation

Completed

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

Cerebrospinal Fluid Leak

United States, Germany, Spain, Czechia
Baxter Healthcare Corporation

Completed

Remotely Monitoring Patients With Chronic Conditions in Their Home

CHF

United States
Baxter Healthcare Corporation

Completed

Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients (EDEN)

Diabetes | End Stage Renal Disease (ESRD) | CAPD

Colombia
Baxter (Hellas) Ltd

Unknown

Peritoneal Membrane Dysfunction in Peritoneal Dialysis Using Metabolomics

End Stage Renal Disease | Dialysis

Greece
Baxter Healthcare Corporation

Completed

Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty

Hematoma | Seroma

United States
Baxter Healthcare Corporation

Withdrawn

Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR (ECOS)

End Stage Renal Disease | Continuous Ambulatory Peritoneal Dialysis

Colombia
Otto Wagner Hospital

Completed

The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy

Inflammatory Response

Austria
Baxter Healthcare Corporation

Completed

Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery

Cardiopulmonary Bypass | Sternotomy | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy

United States
Baxter Healthcare Corporation

Terminated

Dosing Study of Amino Acids in Seriously Ill Patients

Parenteral Nutrition (No Primary Condition Studied)

United States
Baxter Healthcare Corporation

Completed

Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals

Heart Failure | Hypertension

United States
Baxter Healthcare Corporation

Completed

Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty

Osteoarthritis | Knee Replacement Surgery

United States
Warner Chilcott
Sanofi

Terminated

Bone Microarchitecture in Osteopenic Postmenopausal Women

Osteoporosis

United States, Argentina
Warner Chilcott
Sanofi

Completed

Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects

Osteoporosis

United States
Warner Chilcott
Sanofi

Completed

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

Postmenopausal

United States, Poland, Canada, Croatia, Netherlands
Warner Chilcott
Sanofi

Completed

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Osteoporosis | Osteopenia

United States
Baxter Healthcare Corporation

Completed

Fibrin Sealant Vascular Surgery Study

Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)

United States
Baxter Healthcare Corporation

Completed

FS VH S/D 500 S-apr in Vascular Surgery

Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses

United States
Warner Chilcott
Sanofi

Completed

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

Other Osteoporosis

United Kingdom, United States, Poland, France, Hungary, Netherlands, Czech Republic, Lebanon, Australia, Belgium
Baxter Healthcare Corporation

Completed

A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin

Healthy

Germany
Baxter Healthcare Corporation

Completed

Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

Femoral Vascular Anastomosis

Austria, Germany
Baxter Healthcare Corporation

Completed

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Breast Cancer | Lumpectomy | Mastectomy Plus Axillary Lymph Node Dissection | Lymphatic Leakage

Germany, Austria, France, Italy

Clinical Trials Sponsored by Walter Ling

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations